Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
LB Pharmaceuticals Inc (LBRX) had Free Cash Flow per Share of $-0.83 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-19.05M |
|
-- |
|
-- |
|
$22.10M |
|
$-22.10M |
|
$3.05M |
|
$-19.05M |
|
$-19.05M |
|
$-19.05M |
|
$-19.05M |
|
$-19.05M |
|
$-19.05M |
|
$-22.10M |
|
$-22.00M |
|
28.24M |
|
28.24M |
|
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
$389.07M |
|
$1.53M |
|
$4.41M |
|
$393.48M |
|
$10.91M |
|
-- |
|
$3.88M |
|
$14.79M |
|
$378.69M |
|
$378.69M |
|
$378.69M |
|
28.68M |
|
| Cash Flow Statement Financials | |
$-23.29M |
|
$-0.03M |
|
$93.83M |
|
$250.94M |
|
$321.45M |
|
$70.51M |
|
$2.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
35.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.03% |
|
-5.03% |
|
-4.84% |
|
-5.03% |
|
$13.21 |
|
|
Free Cash Flow per Share |
$-0.83 |
$-0.82 |
|